Mark Zuckerberg and his wife Priscilla Chan have donated $25 million through their foundation to a philanthropic effort organized by Bill Gates to explore new coronavirus treatments. 

The Gates Foundation donated $50 million last week to what it’s calling the “COVID-19 Therapeutics Accelerator.” The initiative brings together life sciences companies to collaborate on the development of new vaccines, diagnostics, and treatments for COVID-19.

“The Therapeutics Accelerator will enable researchers to quickly determine whether or not existing drugs have a potential benefit against COVID-19,” Chan and Zuckerberg said in a press release. “We hope these coordinated efforts will help stop the spread of COVID-19 as well as provide shared, reusable strategies to respond to future pandemics.”

The two donations are the largest from tech billionaires since the coronavirus outbreak. Wellcome and Mastercard are supporting the effort as well. 

The goal of the initiative is to either develop a new drug or adapt an existing treatment that it could help distribute alongside partnering pharmaceutical companies. 

The 15 companies participating in the project kicked off the effort by sharing their proprietary libraries of molecular compounds that have some history of being tested with COVID-19. 

The lineup includes big names in biotech such as Johnson & Johnson, Merck, Pfizer, Sanofi, and Bristol-Myers Squibb. 

Share:
More In Technology
Focusing on Big Tech Stocks Amid Market Volatility as Russia Invades Ukraine
Russia’s invasion of Ukraine sent the stock markets into a frenzy for the end of the week. Managing Director of Equity Research at Wedbush Securities, Dan Ives joined Cheddar News to discuss the shifts he expects for the stock market going forward. "It's going to be volatile. Put on the seat belts. I think we'll look back six, nine months. This was an opportunity, not the time to sell, especially some of the high quality names within tech — Microsoft, Apple leading the charge," he said.
Leafly CEO on Big 2021 Cannabis Jobs Growth, Looking Ahead to NJ, NY Adult Use
Even amid the Great Resignation, the cannabis industry saw major job growth. As of January 2022, the legal industry supported more than 428,000 jobs — a 33 percent increase year-over-year, according to the sixth annual jobs report from Leafly, a website focused on cannabis use and education. Yoko Miyashita, CEO of Leafly, joined Cheddar News' Closing Bell to discuss. “You know we've got big moments coming ahead in New Jersey and New York with adult-use sales starting in New Jersey, hopefully by this fall, with New York quickly to follow," she said. "So we're hugely optimistic about the kind of job growth that those markets can drive with the right type of market setup.
Workplace Cybersecurity Trends in 2022
Jadee Hanson, CIO and CISO at Code42, joins ChedHER to discuss what to look out for in the world of cybersecurity in 2022, and why a diverse workforce is so critical in this industry.
Load More